Oncology Institute, Inc. (NASDAQ:STLN – Get Free Report) saw unusually large options trading on Friday. Stock investors purchased 41,482 call options on the company. This represents an increase of approximately 9,159% compared to the average volume of 448 call options.
Oncology Institute Stock Performance
Oncology Institute stock traded up $1.59 during midday trading on Friday, hitting $6.58. 4,626,830 shares of the company’s stock were exchanged, compared to its average volume of 1,910,354. Oncology Institute has a 52-week low of $2.32 and a 52-week high of $7.05.
Oncology Institute Company Profile
Oncology Institute is a physician-led healthcare company focused on delivering specialized cancer care through an integrated oncology platform. Its services are designed to support patients throughout the cancer-care journey, including diagnosis, treatment planning, chemotherapy and other medical oncology services, supportive care, and ongoing disease management.
The company’s business model emphasizes value-based oncology care, with care coordination and clinical programs intended to improve outcomes while managing the overall cost of treatment.
See Also
- Five stocks we like better than Oncology Institute
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
- Why the Landlord of the AI Boom Could Outlast the Chipmakers
Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.
